研究案内

research information

論文

教室欧文誌上発表

2016年度

No Title Journal Author
1 Predictive Value of Neutrophil/Lymphocyte Ratio for Efficacy of Preoperative Chemotherapy in Triple-Negative Breast Cancer Annals of Surgical Oncology 23:1104–1110, 2016 Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
2 Clinicopathological Correlations of Autophagy-related Proteins LC3, Beclin 1 and p62 in Gastric Cancer Anticancer Research 36: 129-136, 2016 Masuda Go, Yashiro M, Kitayama K, Miki Y, Kasashima H, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Sakurai K, Toyokawa T, Kubo N, Tanaka H, Muguruma K, Ohira M, Hirakawa K
3 Tumor-associated macrophages extend along lymphatic flow in the pre-metastatic lymph nodes of human gastric cancer Annals of Surgical Oncology 23: 230-235, 2016 Go Y, Tanaka H, Tokumoto M, Sakurai K, Toyokawa T, Kubo N, Muguruma K, Maeda K, Ohira M, Hirakawa K
4 Optimal management for patients not meeting the inclusion criteria after endoscopic submucosal dissection for gastric cancer Surgical Endoscopy 30(6):2404-14, 2016 Toyokawa T, Ohira M, Tanaka H, (Minamino H), Sakurai K, (Nagami Y), Kubo N, Yamamoto A, (Sano K), Muguruma K, (Tominaga K), (Nebiki H), Yamashita Y, (Arakawa T), Hirakawa K
5 Has widespread use of biologic and immunosuppressant therapy for ulcerative colitis affected surgical trends? Results of a questionnaire survey of surgical institutions in Japan Surgery Today 46(8):930-8, 2016 (Kimura H), (Takahashi K), (Futami K), (Ikeuchi H), (Tatsumi K), (Watanabe K), Maeda K, (Watadani Y), (Nezu R), (Kameyama H), (Nakao S), (Kurachi K), (Hotokezaka M), (Otsuka K), (Watanabe T), (Ozawa H)
6 Predictive potential of preoperative nutritional status in long-term outcome projections for patients with gastric cancer Annals of Surgical Oncology 23: 525–533, 2016 Sakurai K, Ohira M, Tamura T, Toyokawa T, Amano R, Kubo N, Tanaka H, Muguruma K, Yashiro M, Maeda K, Hirakawa K
7 Elevated alpha1-acid glycoprotein in gastric cancer patients inhibits the anticancer effects of paclitaxel, effects restored by co-administration of erythromycin Clinical and Experimental Medicine 16(4):585-592, 2016 (Ohbatake Y), (Fushida S), (Tsukada T), (Kinoshita J), (Oyama K), (Hayashi H), (Miyashita T), (Tajima H), (Takamura H), (Ninomiya I), Yashiro M, Hirakawa K, (Ohta T)
8 Lysyl oxidase is associated with the epithelial-mesenchymal transition of gastric cancer cells in hypoxia Gastric Cancer 19:431–442, 2016 Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K
9 Reduction of prostaglandin transporter predicts poor prognosis associated with angiogenesis in gastric adenocarcinoma Journal of Gastroenterology and Hepatology 31: 376–383, 2016 (Takeda S), (Tanigawa T), (Watanabe T), (Tatsuwaki H), (Nadatani Y), (Otani K), (Nagami Y), (Tanaka F), (Kamata N), (Yamagami H), (Shiba M), (Tominaga K), (Fujiwara Y), Muguruma K, Ohira M, Hirakawa K, (Arakawa T)
10 Clinical verification of sensitivity to preoperative chemotherapy in cases of androgen receptor-expressing positive breast cancer British Journal of Cancer 114: 14-20, 2016 Asano Y, Kashiwagi S, Onoda N, Kurata K, Morisaki T, Noda S, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
11 Histopathological analysis of anaplastic thyroid carcinoma cases with long-term survival: A report from the anaplastic thyroid carcinoma research consortium of Japan Endocrine Journal 63, 441-447, 2016 (Hirokawa M), (Sugitani I), (Kakudo K), (Sakamoto A), (Higashiyama T), (Sugino K), (Toda K), (Ogasawara S), (Yoshimoto S), (Hasegawa Y), (Imai T), Onoda N, (Orita Y), (Kammori M)
12 Prognostic significance of the preoperative ratio of C-reactive protein to albumin in patients with colorectal cancer Anticancer Research 36: 995-1001, 2016 Shibutani M, Maeda K, Nagahara H, Iseki Y, Ikeya T, Hirakawa K
13 Predictive factors for the occurrence of four or more axillary lymph node metastases in ER-positive and HER2-negative breast cancer patients with positive sentinel node: A retrospective cohort study International Journal of Surgery 26: 1-5, 2016 Noda S, Onoda N, Asano Y, Kurata K, Tokumoto M, Morisaki T, Kashiwagi S, Takashima T, Hirakawa K
14 A phase II, multicenter, single-arm trial of eribulin as first-line chemotherapy for HER2-negative locally advanced or metastatic breast cancer Springerplus 5:164, (Online 8pages), 2016 Takashima T, (Tokunaga S), Tei S, Nishimura S, Kawajiri H, Kashiwagi S, Yamagata S, Noda S, Nishimori T, Mizuyama Y, Sunami T, Tezuka K, Ikeda K, Ogawa Y, Onoda N, Ishikawa T, (Kudoh S), (Takada M), Hirakawa K
15 Taxanes versus S-1 as the first-line chemotherapy for metastatic breast cancer (SELECT BC): an open-label, non-inferiority, randomised phase 3 trial Lancet Oncology 17: 90-8, 2016 Takashima T, (Mukai H), (Hara F), (Matsubara N), (Saito T), (Takano T), (Park Y), (Toyama T), (Hozumi Y), (Tsurutani J), (Imoto S), (Watanabe T), (Sagara Y), (Nishimura R), (Shimozuma K), (Ohashi Y); SELECT BC Study Group
16 Establishment and characterization of new cell lines of anaplastic pancreatic cancer, which is a rare malignancy: OCUP-A1 and OCUP-A2 BMC Cancer 16:268: (Online 13pages), 2016 Miura K, Kimura K, Amano R, Yamazoe S, Ohira G, Murata A, Nishio K, Hasegawa T, Yashiro M, Nakata B, Ohira M, Hirakawa K
17 Fibroblast growth factor receptor signaling as therapeutic targets in gastric cancer World Journal of Gastroenterology 22: 2415-2423, 2016 Yashiro M, Matsuoka T.
18 Current status in remnant gastric cancer after distal gastrectomy World Journal of Gastroenterology 22: 2424-2433, 2016 Ohira M, Toyokawa T, Sakurai K, Kubo N, Tanaka H, Muguruma K, Yashiro M, Onoda N, Hirakawa K
19 Tumour-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to neoadjuvant chemotherapy of aggressive breast cancer British Journal of Surgery 103: 845-854, 2016 Asano Y, Kashiwagi S, Goto W, Kurata K, Noda S, Takashima T, Onoda N, (Tanaka S), (Ohsawa M), Hirakawa K
20 Current state of and problems related to cancer of the intestinal tract associated with crohn's disease in Japan Anticancer Research 36: 3761-3766, 2016 (Higashi D), (Katsuno H), (Kimura H), (Takahashi K), (Ikeuchi H), (Kono T), (Nezu R), (Hatakeyama K), (Kameyama H), (Sasaki I), (Fukushima K), (Watanabe K), (Kusunoki M), (Araki T), Maeda K, (Kameoka S), (Itabashi M), (Nakao S), (Maeda K), (Ohge H), (Watadani Y), (Watanabe T), (Sunami E), (Hotokezaka M), (Sugita A), (Funayama Y), (Futami K)
21 Platelet-lymphocyte ratio as a useful predictor of the therapeutic effect of neoadjuvant chemotherapy in breast cancer PLoS One 11: e0153459(Online 9pages)2016 Asano Y, Kashiwagi S, Onoda N, Noda S, Kawajiri H, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
22 Tumor-associated macrophages induce capillary morphogenesis of lymphatic endothelial cells derived from human gastric cancer Cancer Science 107: 1101-1109, 2016 Tauchi Y, Tanaka H, (Kumamoto K), Tokumoto M, Sakimura C, Sakurai K, Kimura K, Toyokawa T, Amano R, Kubo N, Muguruma K, Yashiro M, Maeda K, Ohira M, Hirakawa K
23 A randomized phase III trial comparing S-1 versus UFT as adjuvant chemotherapy for stage II/III rectal cancer (JFMC35-C1: ACTS-RC) Annals of Oncology 27: 1266-1272, 2016 (Oki E), (Murata A), (Yoshida K), Maeda K, (Ikejiri K), (Munemoto Y), (Sasaki K), (Matsuda C), (Kotake M), (Suenaga T), (Matsuda H), (Emi Y), (Kakeji Y), (Baba H), (Hamada C), (Saji S), (Maehara Y)
24 The pretreatment Controlling Nutritional Status (CONUT) score is an independent prognostic factor in patients with resectable thoracic esophageal squamous cell carcinoma: results from a retrospective study BMC Cancer 16:722, (Online 11pages), 2016 Toyokawa T, Kubo N, Tamura T, Sakurai K, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M
25 Prognostic significance of microRNA-21 expression in patients with unresectable metastatic colon cancer Anticancer Research 36: 5145-5152, 2016 Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Ikeya T, Matsutani S, Kimura K, Toyokawa T, Amano R, Tanaka H, Muguruma K, Hirakawa K, Ohira M
26 The safety and efficacy of weekly paclitaxel administration for anaplastic thyroid cancer patients: A nationwide prospective study Thyroid 26: 1293-1299, 2016 Onoda N, (Sugino K), (Higashiyama T), (Kammori M), (Toda K), (Ito K), (Yoshida A), (Suganuma N), (Nakashima N), (Suzuki S), (Tsukahara K), (Noguchi H), (Koizumi M), (Nemoto T), (Hara H), (Miyauchi A), (Sugitani I)
27 CXCL1eChemokine (C-X-C Motif) receptor 2 signaling stimulates the recruitment of bone marrowed-derived mesenchymal cells into diffuse-type gastric cancer stroma American Journal of Pathology 186: 3028-3039, 2016 Kasashima H, Yashiro M, (Nakamae H), Kitayama K, Masuda G, Kinoshita H, Fukuoka T, Hasegawa T, (Nakane T), (Hino M), Hirakawa K, Ohira M
28 The significance of the C‑reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer Springerplus 5:1798, (Online 8pages), 2016 Shibutani M, Maeda K, Nagahara H, Iseki Y, Hirakawa K, Ohira M
29 Low preoperative prognostic nutritional index predicts poor survival post-gastrectomy in elderly patients with gastric cancer Annnals of Surgical Oncology 23: 3669-3676, 2016 Sakurai K, Tamura T, Toyokawa T, Amano R, Kubo N, Tanaka H, Muguruma K, Yashiro M, Maeda K, Ohira M, Hirakawa K
30 Growth arrest by activated BRAF and MEK inhibition in human anaplastic thyroid cancer cells International Journal of Oncology 49: 2303-2308, 2016 Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Hirakawa K, Ohira M
31 Giant duodenal ulcers after neurosurgery for brainstem tumors that required reoperation for gastric disconnection: a report of two cases BMC Surgery 16: 75, (Online 5pages), 2016 Nobori C, Kimura K, Ohira G, Amano R, Yamazoe S, Tanaka H, (Naito K), (Takami T), Hirakawa K, Ohira M

2015年度

No Title Journal Author
1 Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer Surgery Today 45: 315–321, 2015 Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K
2 Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer Journal of Cancer Research and Clinical Oncology 141: 307–313, 2015 Ikeya T, Shibutani M, Maeda K, Sugano K, Nagahara H, Ohtani H, Hirakawa K
3 131I abnormal uptake by the thyroid bed from zuckerkandl tubercle diagnosis by 131I SPECT/CT Clinical Nuclear Medicine 40: 275-277, 2015 (Kawabe J), (Higashiyama S), (Kotani K), Onoda N, (Shiomi S)
4 New molecular staging with G-factor supplements TNM classification in gastric cancer: a multicenter collaborative research by the Japan Society for Gastroenterological Carcinogenesis G-Project committee Gastric Cancer 18: 119-128, 2015 Sawada T, Yashiro M, (Sentani K), (Oue N), (Yasui W), (Miyazaki K), (Kai K), (Fushida S), (Fujimura T), Ohira M, (Kakeji Y), (Natsugoe S), (Shirabe K), (Nomura S), (Shimada Y), (Tomita N), Hirakawa K, (Maehara Y)
5 Primary gastric small cell carcinoma: a series of seven cases Anticancer Research 35: 563-567, 2015 Toyokawa T, Tanaka H, Muguruma K, Tamura T, Sakurai K, Kubo N, Ohira M, Hirakawa K.
6 Expression of xCT as a predictor of disease recurrence in patients with colorectal cancer Anticancer Research 35: 677-682, 2015 Sugano K, Maeda K, Ohtani H, Nagahara H, Shibutani M, Hirakawa K
7 Significant cytostatic effect of everolimus on a gefitinib-resistant anaplastic thyroid cancer cell line harboring PI3KCA gene mutation Molecular and Clinical Oncology 3: 522-526, 2015 Onoda N, Nakamura M, Aomatsu N, Noda S, Kashiwagi S, Kurata K, (Uchino S), Hirakawa K
8 Anaplastic thyroid carcinoma accompanied by uncontrollable eosinophilia Internal Medicine 54: 611-616, 2015 (Shiraishi J), (Koyama H), (Seki M), (Hatayama M), (Naka M), (Kurajoh M), (Okazaki H), (Shoji T), (Moriwaki Y), (Yamamoto T), (Tsuchida Y), (Tsukamoto Y), (Hirota S), Onoda N, (Namba M)
9 Impact of body mass index on surgical outcomes after esophagectomy for patients with esophageal squamous cell carcinoma Journal of Gastrointestinal Surgery 19: 226-233, 2015 Hasegawa T, Kubo N, Ohira M, Sakurai K, Toyokawa T, Yamashita Y, Yamazoe S, Kimura K, Nagahara H, Amano R, Shibutani M, Tanaka H, Muguruma K, Ohtani H, Yashiro M, Maeda K, Hirakawa K
10 Prognostic significance of the preoperative serum C-reactive protein level in patients with stage IV colorectal cancer Surgery Today 45: 315–321, 2015 Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K
11 T-stage and positive sentinel nodes ratio are the useful factors to predict non-sentinel node metastasis in breast cancer patients with macro-metastasis in the sentinel node International Journal of Surgery 14: 56–60, 2015 Noda S, Onoda N, Asano Y, Kurata K, Kashiwagi S, Kawajiri H, Takashima T, Hirakawa K
12 Maintenance of the nutritional prognostic index predicts survival in patients with unresectable metastatic colorectal cancer Journal of Cancer Research and Clinical Oncology 141: 307-313, 2015 Ikeya T, Shibutani M, Maeda K, Sugano K, Nagahara H, Ohtani H, Hirakawa K
13 Salvage surgery after chemotherapy with S-1 plus cisplatin for α-fetoprotein-producing gastric cancer with a portal vein tumor thrombus: a case report BMC Surgery 15: 5, (Online 4pages), 2015 Nakao S, Nakata B, Tendo M, Kuroda K, Hori T, (Inaba M), Hirakawa K, Ishikawa T
14 Efficacy of intracorporeal reinforcing sutures for anastomotic leakage after laparoscopic surgery for rectal cancer Surgical Endoscopy 29: 3535–3542, 2015 Maeda K, Nagahara H, Shibutani M, Ohtani H, Sakurai K, Toyokawa T, Muguruma K, Tanaka H, Amano R, Kimura K, Sugano K, Ikeya T, Iseki Y, Hirakawa K
15 A preoperative low nutritional prognostic index correlates with the incidence of incisional surgical site infections after bowel resection in patients with Crohn’s disease Surgery Today 45: 1366-1372, 2015 Maeda K, Nagahara H, Shibutani M, Otani H, Sakurai K, Toyokawa T, Tanaka H, Kubo N, Muguruma K, (Kamata N), (Yamagami H), Hirakawa K
16 Prostaglandin D synthase is a potential novel therapeutic agent for the treatment of gastric carcinomas expressing PPARγ International Journal of Cancer 137: 1235-1244, 2015 Fukuoka T, Yashiro M, Kinoshita H, Morisaki T, Hasegawa T, Hirakawa T, Aomatsu N, (Takeda H), (Maruyama T), Hirakawa K
17 Ambulatory sentinel lymph node biopsy preceding neoadjuvant therapy in patients with operable breast cancer: a preliminary study World Journal of Surgical Oncology 13: 53(Online 6pages), 2015 Kashiwagi S, Onoda N, Asano Y, Kurata K, Noda S, Kawajiri H, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
18 Nonfunctional adrenocortical carcinoma initially presenting as retroperitoneal hemorrhage BMC Surgery 15: 46(Online 6pages), 2015 Kashiwagi S, Amano R, Onoda N, Noda S, Hirata K, Asano Y, Kurata K, Miura K, Yamazoe S, Kimura K, (Ohsawa M), (Kitagawa S), Hirakawa K
19 Regulation of neutrophil infiltration into peritoneal cavity by laparoscopic gastrectomy Hepatogastroenterology 62: 546-550, 2015 Yoshii M, Tanaka H, Ohira M, Muguruma K, Lee T, Sakurai K, Kubo N, Maeda K, Hirakawa K
20 A case of bilateral pheochromocytoma during pregnancy BMC Surgery 15: 55(Online 5pages), 2015 Kitayama K, Kashiwagi S, Amano R, Noda S, Ohira G, Yamazoe S, Kimura K, (Hamamoto K), (Hamuro A), (Ohsawa M), Onoda N, Hirakawa K
21 The pretreatment albumin to globulin ratio predicts chemotherapeutic outcomes in patients with unresectable metastatic colorectal cancer BMC Cancer 15: 347(Online 7pages), 2015 Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K
22 Two-surgeon technique for liver transection using precoagulation by a soft-coagulation system and ultrasonic dissection Hepatogastroenterology 62: 389-392, 2015 Yamada N, Amano R, Kimura K, Murata A, Yashiro M, (Tanaka S), (Wakasa K), Hirakawa K
23 Pancreatectomy with major arterial resection after neoadjuvant chemoradiotherapy gemcitabine and S-1 and concurrent radiotherapy for locally advanced unresectable pancreatic cancer Surgery 158: 191-200, 2015 Amano R, Kimura K, Nakata B, Yamazoe S, (Motomura H), (Yamamoto A), (Tanaka S), Hirakawa K
24 The outcome of surgical treatment for elderly patients with gastric carcinoma Journal of Surgical Oncology 111: 848-854, 2015 Sakurai K, Muguruma K, Nagahara H, Kimura K, Toyokawa T, Amano R, Kubo N, Tanaka H, Ohtani H, Yashiro M, Maeda K, Ohira M, Hirakawa K
25 Tumor necrosis factor α decreases glucagon-like peptide-2 expression by up-regulating G-protein-coupled receptor 120 in Crohn disease American Journal of Pathology 185: 185-196, 2015 (Tsukahara T), (Watanabe K), (Watanabe T), (Yamagami H), (Sogawa M), (Tanigawa T), (Shiba M), (Tominaga K), (Fujiwara Y), Maeda K, Hirakawa K, (Arakawa T)
26 Epigenetic modulation and repression of miR-200b by cancer-associated fibroblasts contribute to cancer invasion and peritoneal dissemination in gastric cancer Carcinogenesis 36: 133-141, 2015 (Kurashige J), (Mima K), (Sawada G), (Takahashi Y), (Eguchi H), (Sugimachi K), (Mori M), (Yanagihara K), Yashiro M, Hirakawa K, (Baba H), (Mimori K)
27 Protein-bound polysaccharide K suppresses tumor fibrosis in gastric cancer by inhibiting the TGF-β signaling pathway Oncology Report 33: 553-558, 2015 (Shinbo T), (Fushida S), (Tsukada T), (Harada S), (Kinoshita J), (Oyama K), (Okamoto K), (Ninomiya I), (Takamura H), (Kitagawa H), (Fujimura T), Yashiro M, Hirakawa K, (Ohta T)
28 Pertuzumab in combination with trastuzumab and docetaxel for HER2-positive metastatic breast cancer Expert Review of Anticancer Therapy 15: 17-26, 2015 Kawajiri H, Takashima T, Kashiwagi S, Noda S, Onoda N, Hirakawa K
29 The prognostic significance of a postoperative systemic inflammatory response in patients with colorectal cancer World Journal of Surgical Oncology 13:194 (Online 8pages), 2015 Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K
30 Alteration of CD4 T cell subsets in metastatic lymph nodes of human gastric cancer Oncology Reports 34: 639-647, 2015 Okita Y, Ohira M, Tanaka H, Tokumoto M, Go Y, Sakurai K, Toyokawa T, Kubo N, Muguruma K, Sawada T, Maeda K, Hirakawa K
31 Concept and design of a nationwide prospective feasibility/efficacy/safety study of weekly paclitaxel for patients with pathologically confirmed anaplastic thyroid cancer (ATCCJ-PTX-P2) BMC Cancer 15:475(Online 5pages), 2015 Onoda N, (Sugitani I), (Higashiyama T), (Hara H), (Ito K), (Kammori M), (Sugino K), (Suzuki S), (Toda K), (Yoshida A), (Miyauchi A)
32 Treatment rationale and study design for clinical trial on the efficacy of UFT/LV for stage II colorectal cancer with risk factors for recurrence (JFMC46-1201) Clinical Colorectal Cancer 14(4):277-80, 2015 (Sadahiro S), (Morita S), (Sasaki K), (Sakamoto K), (Ohge H), (Takahashi T), (Tsuchiya T), (Sato T), (Kondo K), (Ogata Y), (Masuko H), (Baba H), Maeda K, (Hamada M), (Itabashi M), (Nishimura G), (Takahashi K), (Ikeda M), (Taguri M), (Kodaira S)
33 The prognostic significance of the postoperative prognostic nutritional index in patients with colorectal cancer BMC Cancer 15:521(Online 10pages), 2015 Shibutani M, Maeda K, Nagahara H, Ohtani H, Iseki Y, Ikeya T, Sugano K, Hirakawa K
34 Impact of the preoperative controlling nutritional status (CONUT) score on the survival after curative surgery for colorectal cancer PLoS One 10: e0132488 (Online 13pages) 2015 Iseki Y, Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Muguruma K, Tanaka H, Toyokawa T, Sakurai K, Hirakawa K
35 Nestin expression as an independent indicator of poor prognosis for patients with anaplastic thyroid cancer Oncology Letters 10: 850-856, 2015 Kurata K, Onoda N, Noda S, Kashiwagi S, Asano Y, Kawajiri H, Takashima T, (Tanaka S), (Ohsawa M), Hirakawa K
36 Impact of chemoradiation-induced myelosuppression on prognosis of patients with locally advanced esophageal cancer after chemoradiotherapy followed by esophagectomy Anticancer Research 35: 4889-4895, 2015 Ohira M, Kubo N, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Hirakawa K
37 Glasgow prognostic score as a prognostic clinical marker in T4 esophageal squamous cell carcinoma Anticancer Research 35: 4897-4901, 2015 Ohira M, Kubo N, Masuda G, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Hirakawa K
38 Significance of markers of systemic inflammation for predicting survival and chemotherapeutic outcomes and monitoring tumor progression in patients with unresectable metastatic colorectal cancer Anticancer Research 35: 5037-5046, 2015 Shibutani M, Maeda K, Nagahara H, Ohtani H, Sakurai K, Yamazoe A, Kimura K, Toyokawa T, Amano R, Kubo N, Tanaka H, Muguruma K, Ohira M, Hirakawa K
39 Exosomal miRNAs from peritoneum lavage fluid as potential prognostic biomarkers of peritoneal metastasis in gastric cancer PLoS One 10: e0130472(Online 13pages), 2015 (Tokuhisa M), (Ichikawa Y), (Kosaka N), (Ochiya T), Yashiro M, Hirakawa K, (Kosaka T), (Makino H), (Akiyama H), (Kunisaki C), (Endo I)
40 Diaphragmatic herniation after transthoracic esophagectomy for esophageal cancer Surgery Current Research 5:(Online 5pages), 2015 Ohira M, Kubo N, Yamashita Y, Sakurai K, Toyokawa T, Tanaka T, Muguruma K, Hirakawa K
41 Inflammation-based factors and prognosis in patients with colorectal cancer World Journal of Gastrointestinal Oncology 7: 111-117, 2015 Maeda K, Shibutani M, Otani H, Nagahara H, Ikeya T, Iseki Y, Tanaka H, Muguruma K, Hirakawa K
42 Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer World Journal of Gastroenterology 21: 9966-9973, 2015 Shibutani M, Maeda K, Nagahara H, Ohtani H, Sakurai K, Yamazoe S, Kimura K, Toyokawa T, Amano R, Tanaka H, Muguruma K, Hirakawa K
43 Long-term survival with complete remission after hepatic arterial infusion chemotherapy for liver metastasis from gastric cancer: a case report World Journal of Surgical Oncology 13: 268 (Online 5pages), 2015 Toyokawa T, Ohira M, Sakurai K, Amano R, Kubo N, Tanaka H, Muguruma K, Hirakawa K
44 Identification of tumour-reactive lymphatic endothelial cells capable of inducing progression of gastric cancer British Journal of Cancer 113: 1046-1054, 2015 Tokumoto M, Tanaka H, Tauchi Y, Kasashima H, Kurata K, Yashiro M, Sakurai K, Toyokawa T, Kubo N, Amano R, Kimura K, Muguruma K, Maeda K, Ohira M, Hirakawa K
45 Diffuse-type Gastric Cancer Cells Switch Their Driver Pathways from FGFR2 Signaling to SDF1/CXCR4 Axis in Hypoxic Tumor Microenvironments Carcinogenesis 36: 1511-1520, 2015 Kinoshita H, Yashiro M, Fukuoka T, Hasegawa T, Morisaki T, Kasashima H, Masuda G, Noda S, Hirakawa K
46 The significance and the predictive factors of microscopic lymph node metastasis in patients with clinically node negative papillary thyroid cancer: A retrospective cohort study International Journal of Surgery 20: 52–57, 2015 Noda S, Onoda N, Morisaki T, Kashiwagi S, Takashima T, Hirakawa K
47 The role of adjuvant chemotherapy for patients with stage IB gastric cancer Anticancer Research 35 : 4091-4097, 2015 Toyokawa T, Ohira M, Sakurai K, Kubo N, Tanaka H, Muguruma K, Hirakawa K
48 Binding of galectin-3, a β-galactoside-binding lectin, to MUC1 protein enhances phosphorylation of extracellular signal-regulated kinase 1/2 (ERK1/2) and Akt, promoting tumor cell malignancy Journal of Biological Chemistry 290: 26125-26140, 2015 (Mori Y), (Akita K), Yashiro M, Sawada T, Hirakawa K, (Murata T), (Nakada H)
49 Programmed Death-1 Ligand-1 (PDL1) Expression Is Associated with the Prognosis of Patients with Stage II/III Gastric Cancer Anticancer Research 35: 5369-5376, 2015 Tamura T, Ohira M, Tanaka H, Muguruma K, Toyokawa T, Kubo N, Sakurai K, Amano R, Kimura K, Shibutani M, Maeda K, Hirakawa K
50 Bone marrow-derived stromal cells are associated with gastric cancer progression British Journal of Cancer 113: 443–452, 2015 Kasashima H, Yashiro M, (Nakamae H), Masuda G, Kinoshita H, Morisaki T, Fukuoka T, Hasegawa T, Sakurai K, Toyokawa T, Kubo N, Tanaka H, Muguruma K, Ohira M, (Nakane T), (Hino M), Hirakawa K
51 Partial mastectomy using manual blunt dissection (MBD) in early breast cancer BMC Surgery 15: 117(Online 5pages), 2015 Kashiwagi S, Onoda N, Asano Y, Kurata K, Morisaki T, Noda S, Kawajiri H, Takashima T, Hirakawa K
52 Evaluation of the prognostic significance of ‘High-risk Stigmata’ in the international consensus guidelines 2012 for Intraductal papillary mucinous neoplasm Surgery Current Research 5:234 (Online 5pages), 2015 Kimura K, Amano R, Yamazoe S, Ohira G, Miura K, Nishio K, Sakurai K, Toyokawa T, Nakata B, Murata A, Shimizu S, (Tanaka S), (Ohsawa M), Ohira M, Hirakawa K
53 Endoscopic closure of gastrocutaneous leakage with polyglycolic acid sheets Endoscopy 47: E455-E456, 2015 (Nagami Y), (Shiba M), (Tominaga K), Yamazoe S, Amano R, (Fujiwara Y), (Arakawa T)

2014年度

No Title Journal Author
1 Focused approach to ectopic mediastinal parathyroid surgery assisted by radio-guided navigation Surgery Today 44: 533-539, 2014 Onoda N, Ishikawa T,(Nishiyama N), (Kawabe J), Takashima T, Hirakawa K
2 The impact of the number of occult metastatic lymph nodes on postoperative relapse of resectable esophageal cancer Diseases of the Esophagus 27: 63-71, 2014 Morimoto J, Tanaka H, Ohira M, Kubo N, Muguruma K, Sakurai K, Yamashita Y, Maeda K, Sawada T, Hirakawa K
3 Role of tumor-infiltrating CD11b+ antigen-presenting cells in the progression of gastric cancer Journal of Surgical Research 186: 192-200, 2014 Okita Y, Tanaka H, Ohira M, Muguruma K, Kubo N, Watanabe M, (Fukushima W), Hirakawa K
4 E‑cadherin expression and cell proliferation in the primary tumor and metastatic lymph nodes of papillary thyroid microcarcinoma Molecular and Clinical Oncology 2: 226-232, 2014 Nakamura M, Onoda N, Noda S, Kashiwagi S, Aomatsu N, Kurata K, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K
5 Thoracoscopic esophagectomy in the prone position versus in the lateral position for patients with esophageal cancer : A comparison of short-term surgical results Surgical Laparoscopy, Endoscopy & Percutaneous Techniques 24: 158-163, 2014 Kubo N, Ohira M, Yamashita Y, Sakurai K, Lee T, Toyokawa T, Tanaka H, Muguruma K, Kimura K, Nagahara H, Amano R, Noda E, Ohtani H, Yashiro M, Maeda K, Hirakawa K
6 Cancer-associated fibroblasts might sustain the stemness of scirrhous gastric cancer cells via transforming growth factor-β signaling International Journal of Cancer 134: 1785–1795 , 2014 Hasegawa T, Yashiro M, Nishii T, Matsuoka J, Fuyuhiro Y, Morisaki T, Fukuoka T, (Shimizu K), (Shimizu T), (Miwa A), Hirakawa K
7 The impact of combined thoracoscopic and laparoscopic surgery on pulmonary complications after radical esophagectomy in patients with resectable esophageal cancer Anticancer Research 34 :2399-2404, 2014 Kubo N, Ohira M, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Shibutani M, Yamazoe S, Kimura K, Nagahara H, Amano R, Ohtani H, Yashiro M, Maeda K, Hirakawa K
8 Successful resection of esophageal carcinoma with aberrant right subclavian artery using video-assisted thoracoscopic surgery: report of two cases Anticancer Research 34: 899-904, 2014 Kasashima H, Kubo N, Ohira M, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Shibutani M, Yamazoe S, Kimura K, Nagahara H, Amano R, Ohtani H, Yashiro M, Maeda K, Hirakawa K
9 Laparoscopy-assisted total gastrectomy: a simplified approach International Surgery 99: 79-85, 2014 Muguruma K, Tanaka H, Sakurai K, Toyokawa T, Kubo N, Yamashita Y, Sawada T, Ohira M, Hirakawa K
10 Gastric metastasis from renal cell carcinoma with gastrointestinal bleeding: a case report and review of the literature International Surgery 99: 86-90, 2014 Sakurai K, Muguruma K, Yamazoe S, Kimura K, Toyokawa T, Amano R, Kubo N, Tanaka H, Yashiro M, Ohira M, Hirakawa K
11 Portal vein stenting to treat portal vein stenosis in a patient with malignant tumor and gastrointestinal bleeding International Surgery 99: 91-95, 2014 Sakurai K, Amano R, (Yamamoto A), (Nishida N), Matsutani S, Hirata K, Kimura K, Muguruma K, Toyokawa T, Kubo N, Tanaka H, Yashiro M, Ohira M, Hirakawa K
12 Establishment, characterization and comparison of seven authentic anaplastic thyroid cancer cell lines retaining clinical features of the original tumors World Journal of Surgery 38: 688-695, 2014 Onoda N, Nakamura M, Aomatsu N, Noda S, Kashiwagi S, Hirakawa K
13 Prognostic significance of pathological complete response following neoadjuvant chemotherapy for operable breast cancer Oncology Letters 7: 663-668, 2014 Kawajiri H, Takashima T, Aomatsu N, Kashiwagi S, Noda S, Onoda N, Ishikawa T, Hirakawa K
14 A rare recurrence of bilateral breast cancer in the esophagus coincidentally associated with primary gastric cancer: a case report Journal of Medical Case Reports 8: 58, (Online 6pages) 2014 Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K
15 Strategy of operative treatment of hyperparathyroidism using US scan and 99mTc-MIBI SPECT/CT Endocrine Journal 61: 225-230, 2014 Noda S, Onoda N, Kashiwagi S, Kawajiri H, Takashima T, Ishikawa T, (Yoshida A), (Higashiyama S), (Kawabe J), (Imanishi Y), (Tahara H), (Inaba M), (Osawa M), Hirakawa K
16 A phase Ⅱ study of five peptides combination with oxaliplatin-based chemotherapy as a first-line therapy for advanced colorectal cancer (FXV study) Journal of Translational Medicine 12:108, (Online 10pages) 2014 (Hazama S), (Nakamura Y), Tanaka H, Hirakawa K, (Tahara K), (Shimizu R), (Ozasa H), (Etoh R), (Sugiura F), (Okuno K), (Furuya T), (Nishimura T), (Sakata K), (Yoshimatsu K), (Takenouchi H), (Tsunedomi R), (Inoue Y), (Kanekiyo S), (Shindo Y), (Suzuki N), (Yoshino S), (Shinozaki H), (Kamiya A), (Furukawa H), (Yamanaka T), (Fujita T), (Kawakami Y), (Oka M)
17 Coexpression of EpCAM, CD44 variant isoforms and claudin-7 in anaplastic thyroid carcinoma PLoS One 9: e94487, (Online 13pages) 2014 (Okada T), (Nakamura T), (Watanabe T), Onoda N, (Ashida A), (Okuyama R), (Ito K)
18 Revisiting the guidelines issued by the japanese society of thyroid surgeons and japan association of endocrine surgeons: A gradual move towards consensus between japanese and western practice in the management of thyroid carcinoma World Journal of Surgery 38: 2002–2010, 2014 (Takami H), (Ito Y), (Okamoto T), Onoda N, (Noguchi H), (Yoshida A)
19 The niche component periostin is produced by cancer-associated fibroblasts, supporting growth of gastric cancer through ERK activation The American Journal of Pathology 184: 859-870, 2014 (Kikuchi Y), (Kunita A), (Iwata C), (Komura D), (Nishiyama T), (Shimazu K), (Takeshita K), (Shibahara J), (Kii I), (Morishita Y), Yashiro M, Hirakawa K, (Miyazono K), (Kudo A), (Fukayama M), (Kashima TG)
20 MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer Cancer Science 105: 228-235, 2014 (Naito Y), (Sakamoto N), (Oue N), Yashiro M, (Sentani K), (Yanagihara K), Hirakawa K, (Yasui W)
21 A prognostic indicator for the resection of liver metastasis of colorectal cancer Surgery Today 44: 1287-1292, 2014 Amano R, Yamada N, Nakata B, Kimura K, Yashiro M, Ohira M, Hirakawa K
22 Significance of CEA and CA19-9 combination as a prognostic indicator and for recurrence monitoring in patients with stage II colorectal cancer Anticancer Research 34: 3753-3758, 2014 Shibutani M, Maeda K, Nagahara H, Ohtani H, Sakurai K, Toyokawa T, Kubo N, Tanaka H, Muguruma K, Ohira M, Hirakawa K
23 Reactive lymphoid hyperplasia of the thyroid followed by systemic autoimmune diseases: a case report Journal of Medical Case Reports 8:247(Online 6pages) 2014 Onoda N, (Ohsawa M), Kawajiri H, Noda S, Kashiwagi S, Takashima T, Hirakawa K
24 Clinical impact of the extent of lymph node micrometastasis in undifferentiated-type early gastric cancer Oncology 86: 244-252, 2014 Lee T, Tanaka H, Ohira M, Okita Y, Yoshii M, Sakurai K, Toyokawa T, Kubo N, Muguruma K, (Tanaka S), (Ohsawa M), Hirakawa K
25 Predictive factors for change of diabetes mellitus status after pancreatectomy in preoperative diabetic and nondiabetic patients Journal of Gastrointestinal Surgery 18:1597–1603, 2014 Hirata K, Nakata B, Amano R, Yamazoe S, Kimura K, Hirakawa K
26 Phase II study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer Anticancer Research 34: 3583-3588, 2014 Takashima T, (Nakayama T), (Yoshidome K), Kawajiri H, (Kamigaki S), (Tsurutani J), (Arai T), (Ito T), (Komoike Y), (Doi T), (Masuda N), (Miyauchi K), (Miyoshi Y), (Sakamoto J), (Morita S), (Taguchi T)
27 Risk factors for surgical site infection in Japanese patients with ulcerative colitis: a multicenter prospective study Surgery Today 44: 1072-1078, 2014 (Araki T), (Okita Y), (Uchino M), (Ikeuchi H), (Sasaki I), (Funayama Y), (Fukushima K), (Futami K), Maeda K, (Iiai T), (Itabashi M), (Hase K), (Motoya S), (Kitano A), (Mizushima T), (Maeda K), (Kobayashi M), (Mohri Y), (Kusunoki M)
28 Usefulness of non-magnifying narrow-band imaging in screening of early esophageal squamous cell carcinoma: a prospective comparative study using propensity score matching The American Journal of Gastroenterology 109: 845-854, 2014 (Nagami Y), (Tominaga K), (Machida H), (Nakatani M), (Kameda N), (Sugimori S), (Okazaki H), (Tanigawa T), (Yamagami H), Kubo N, (Shiba M), (Watanabe K), (Watanabe T), (Iguchi H), (Fujiwara Y), Ohira M, Hirakawa K, (Arakawa T)
29 Intranodal cytokeratin particles is a predictive marker of efficacy for neoadjuvant therapies in patients with squamous cell carcinoma of the esophagus Hepato-Gastroenterology 61: 1235-1240, 2014 Lee T, Tanaka H, Ohira M, Kubo N, Sakurai K, Toyokawa T, Muguruma K, Yamashita Y, Maeda K, Hirakawa K
30 Lysyl oxidase-like 2 (LOXL2) from stromal fibroblasts stimulates the progression of gastric cancer Cancer Letters 354: 438–446, 2014 Kasashima H, Yashiro M, Kinoshita H, Fukuoka T, Morisaki T, Masuda G, Sakurai K, Kubo N, Ohira M, Hirakawa K
31 Neoadjuvant capecitabine, bevacizumab and radiotherapy for locally advanced rectal cancer: results of a single-institute Phase I study Journal of Radiation Research 55: 1171–1177, 2014 (Miki Y), Maeda K, (Hosono M), Nagahara H, Hirakawa K, (Shimatani Y), (Tsutsumi S), (Miki Y)
32 Comparative proteomics analysis of gastric cancer stem cells PLoS One 9: e110736, (Online 16pages) 2014 Morisaki T, Yashiro M, (Kakehashi A), (Inagaki A), Kinoshita H, Fukuoka T, Kasashima H, Masuda G, Sakurai K, Kubo N, Muguruma K, Ohira M, (Wanibuchi H), Hirakawa K
33 MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer Oncology Report 32: 1720-1726, 2014 (Naito Y), (Yasuno K), (Tagawa H), (Sakamoto N), (Oue N), Yashiro M, (Sentani K), (Goto K), (Shinmei S), (Oo HZ), (Yanagihara K), Hirakawa K, (Yasui W)
34 The role of type D prostanoid receptors and PPARγ in gastric cancer progression Anticancer Research 34 : 2771-2778, 2014 Fukuoka T, Yashiro M, Morisaki T, Kinoshita H, Hasegawa T, Kasashima H, Masuda G, Sakurai K, Toyokawa T, Tanaka H, Kubo N, Muguruma K, Ohira M, Hirakawa K
35 Carbonic anhydrase 9 is associated with chemosensitivity and prognosis in breast cancer patients treated with taxane and anthracycline BMC Cancer 14,(Online 10pages), 2014 Aomatsu N, Yashiro M, Kashiwagi S, Kawajiri H, Takashima T, (Ohsawa M), (Wakasa K), Hirakawa K
36 Comparative study of the antitumor activity of Nab-paclitaxel and intraperitoneal solvent-based paclitaxel regarding peritoneal metastasis in gastric cancer Oncology Reports 32: 89-96, 2014 (Kinoshita J), (Fushida S), (Tsukada T), (Oyama K), (Watanabe T), (Shoji M), (Okamoto K), (Nakanuma S), (Sakai S), (Makino I), (Furukawa H), (Hayashi H), (Nakamura K), (Inokuchi M), (Nakagawara H), (Miyashita T), (Tajima H), (Takamura H), (Ninomiya I), (Fujimura T), Yashiro M, Hirakawa K, (Ohta T)
37 Intranodal lymphangiogenesis precedes development of lymph node metastasis and accelerates progression of gastric cancer Journal of Gastrointestinal Surgery 18: 481–490, 2014 Watanabe M, Tanaka H, Ohira M, Yoshii M, Sakurai K, Toyokawa T, Kubo N, Yamamoto A, Muguruma K, Yamashita Y, Maeda K, Sawada T, Hirakawa K
38 A positive correlation between neutrophils in regional lymph nodes and progression of gastric cancer Anticancer Research 34: 7129-7136, 2014 Tokumoto M, Tanaka H, Ohira M, Go Y, Okita Y, Sakurai K, Toyokawa T, Kubo N, Muguruma K, Maeda K, Sawada T, Hirakawa K
39 Differential impact of the neutrophil-lymphocyte ratio on the survival of patients with stage IV gastric cancer Digestive Surgery 31: 327-333, 2014 Tanaka H, Muguruma K, Toyokawa T, Kubo N, Ohira M, Hirakawa K
40 Early gastric cancer with suspected brain metastasis arising eight years after curative resection: a case report BMC Research Notes 7:818(Online 5pages), 2014 Sakurai K, Muguruma K, Murata A, Toyokawa T, Amano R, Kubo N, Tanaka H, Yashiro M, Maeda K, Ohira M, Hirakawa K
41 MUC1 protein induces urokinase-type plasminogen activator (uPA) by forming a complex with NF-κB p65 transcription factor and binding to the uPA promoter, leading to enhanced invasiveness of cancer cells Journal of Biological Chemistry 289: 35193-35204, 2014 (Mori Y), (Akita K), (Tanida S), (Ishida A), (Toda M), (Inoue M), Yashiro M, Sawada T, Hirakawa K, (Nakada H)
42 Elevated preoperative serum C-reactive protein levels are associated with poor survival in patients with colorectal cancer Hepatogastroenterology 61: 2236-2240, 2014 Shibutani M, Maeda K, Nagahara H, Ohtani H, Sugano K, Ikeya T, Kimura K, Amano R, Kubo N, Tanaka H, Muguruma K, Ohira M, Hirakawa K
43 Clinical and pathological features of five-year survivors after pancreatectomy for pancreatic adenocarcinoma World Journal of Surgical Oncology 12(Online 8pages), 2014 Kimura K, Amano R, Nakata B, Yamazoe S, Hirata K, Murata A, Miura K, Nishio K, Hirakawa T, Ohira M, Hirakawa K

2013年度

No Title Journal Author
1 MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways International Journal of Oncology 42: 887-893, 2013 (Hoshi H), Sawada T, (Uchida M), (Iijima H), Kimura K, Hirakawa K, (Wanibuchi H)
2 Long-term survival of advanced small cell carcinoma of the esophagus after resection: A case report Anticancer Research 33: 595-600, 2013 Muguruma K, Ohira M, Tanaka H, Kubo N, Yamashita Y, Sawada T, (Wakasa K), Hirakawa K
3 Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening International Journal of Oncology 42: 1589-1596, 2013 (Sugishita Y), (Kammori M), (Yamada O), (Poon SS), (Kobayashi M), Onoda N, (Yamazaki K), (Fukumori T), (Yoshikawa KI), (Onose H), (Ishii S), (Yamada E), (Yamada T)
4 C-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer British Journal of Surgery 100: 490-496, 2013 Kashiwagi S, Yashiro M, Takashima T, Aomatsu N, Kawajiri H, Ogawa Y, Onoda N, Ishikawa T, (Wakasa K), Hirakawa K
5 Successful resection of esophageal cancer with right aortic arch by video-assisted thoracoscopic surgery: a case report Anticancer Research 33: 1635-1640, 2013 Kubo N, Ohira M, Lee T, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Kimura K, Nagahara H, Noda E, Amano R, Ohtani H, Yamashita Y, Yashiro M, Maeda K, Hirakawa K
6 SPan-1 is a useful prognostic marker for patients with stage IV gastric cancer who underwent palliative gastrectomy: A retrospective multivariate study World Journal of Surgery 37:1681–1687, 2013 Kubo N, Ohira M, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Nagahara H, Kimura K, Noda E, Amano R, Yamada N, Yashiro M, Maeda K, Sawada T, Hirakawa K.
7 Interstitial pneumonia associated with neoadjuvant chemotherapy in breast cancer Molecular and Clinical Oncology 1: 433-436, 2013 Kawajiri H, Takashima T, Onoda N, Kashiwagi S, Ishikawa T, Hirakawa K
8 Complete eradication of de-differentiated skin recurrence of papillary thyroid carcinoma with weekly docetaxel International Cancer Conference Journal 2: 97–100, 2013 Onoda N, Kawajiri H, Kashiwagi S, Nakamura M, Takashima T, (Osawa M), (Wakasa K), Ishikawa T, Hirakawa K
9 Association of MHC class I expression and lymph node metastasis of gastric carcinoma Hepato-Gastroenterology 60: 611-615, 2013 Yoshii M, Tanaka H, Ohira M, Muguruma K, Sakurai K, Kubo N, Yashiro M, Sawada T,Hirakawa K
10 Design and synthesis of a series of α-benzyl phenylpropanoic acid-type peroxisome proliferator-activated receptor (PPAR) gamma partial agonists with improved aqueous solubility Bioorganic & Medicinal Chemistry 21: 2319-2332, 2013 (Ohashi M), (Oyama T), (Putranto EW), (Waku T), (Nobusada H), (Kataoka K), (Matsuno K), Yashiro M, (Morikawa K), (Huh NH), (Miyachi H)
11 Prognostic predictive values of gemcitabine sensitivity-related gene products for unresectable or recurrent biliary tract cancer treated with gemcitabine alone World Journal of Surgical Oncology 11:117, (Online 7pages) 2013 Murata A, Amano R, Yamada N, Kimura K, Yashiro M, Nakata B, Hirakawa K
12 Expression of E-cadherin and KRAS mutation may serve as biomarkers of cetuximab-based therapy in metastatic colorectal cancer Oncology Letter 5: 1295-1300, 2013 Nakamoto K, Nagahara H, Maeda K, Noda E, Inoue T, Yashiro M, Nishiguchi Y, Ohira M, Hirakawa K
13 Low Expression of Claudin-1 and Presence of Poorly-differentiated Tumor Clusters Correlate with Poor Prognosis in Colorectal Cancer Anticancer Research 33: 3301-3306, 2013 Shibutani M, Noda E, Maeda K, Nagahara H, Ohtani H, Hirakawa K
14 MUC1 and HER2 might be associated with invasive phenotype of intraductal papillary mucinous neoplasm (IPMN) Hepatogastroenterology 60: 1067-1072, 2013 Ohira G, Kimura K, Yamada N, Amano R, Nakata B, Doi Y, Murata A, Yashiro M, (Tanaka S), (Ohsawa M), (Wakasa K), Hirakawa K
15 High efficacy of chemoradiation therapy sensitized by weekly docetaxel for anaplastic thyroid cancer Anticancer Research 33: 3445-3448, 2013 Onoda N, Kashiwagi S, Noda S, Kawajiri H, Takashima T, Ishikawa T, Hirakawa K
16 Adjunctive imprint cytology of core needle biopsy specimens improved diagnostic accuracy for breast cancer Springerplus 2: 372, (Online 7pages) 2013 Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
17 Clinical significance of the sub-classification of 71 cases mucinous breast carcinoma Springerplus 2: 481, (Online 6pages) 2013 Kashiwagi S, Onoda N, Asano Y, Noda S, Kawajiri H, Takashima T, (Ohsawa M), (Kitagawa S), Hirakawa K
18 Laparoscopic adrenalectomy in a patient with situs inversus Journal of the Society of Laparoendoscopic Surgeons 17: 487–490, 2013 Kashiwagi S, Ishikawa T, Onoda N, Kawajiri H, Takashima T, Hirakawa K
19 A high preoperative neutrophil-to-lymphocyte ratio is associated with poor survival in patients with colorectal cancer Anticancer Research 33: 3291-3294, 2013 Shibutani M, Maeda K, Nagahara H, Noda E, Ohtani H, Nishiguchi Y, Hirakawa K
20 In vitro effects of lapatinib with gemcitabine for pancreatic cancer cells Hepatogastroenterology 60: 1484-1487, 2013 Murata A, Nakata B, Komoto M, Hirata K, Kimura K, Amano R, Hirakawa K
21 IGF-1 receptor and IGF binding protein-3 might predict prognosis of patients with resectable pancreatic cancer BMC Cancer 13: 392, (Online 9pages) 2013 Hirakawa T, Yashiro M, Murata A, Hirata K, Kimura K, Amano R, Yamada N, Nakata B, Hirakawa K
22 Glyoxalase 1 as a candidate for indicating the metastatic potential of SN12C human renal cell carcinoma cell clones Oncology Reports 30: 2365-2370, 2013 (Tanaka T), (Kuramitsu Y), (Wang Y), (Baron B, (Kitagawa T), (Tokuda K), Hirakawa K, Yashiro M, (Naito S), (Nakamura K)
23 Meta-analysis of laparoscopic and open surgery for gastric gastrointestinal stromal tumor Anticancer Research 33 : 5031-5041, 2013 Ohtani H, Maeda K, Noda E, Nagahara H, Shibutani M, Ohira M, Muguruma K, Tanaka H, Kubo N, Toyokawa T, Sakurai K, Yamashita Y, Yamamoto A, Hirakawa K
24 Tumor budding and E-cadherin expression are useful predictors of nodal involvement in T1 esophageal squamous cell carcinoma Anticancer Research 33: 5023-5029, 2013 Nakagawa Y, Ohira M, Kubo N, Yamashita Y, Sakurai K, Toyokawa T, Tanaka H, Muguruma K, Shibutani M, Yamazoe S, Kimura K, Nagahara H, Amano, Ohtani H, Yashiro M, Maeda K, Hirakawa K
25 A c-Met inhibitor increases the chemosensitivity of cancer stem cells to the irinotecan in gastric carcinoma British Journal of Cancer 109: 2619–2628, 2013 Yashiro M, Nishii T, Hasegawa T, Matsuzaki T, Morisaki T, Fukuoka T, Hirakawa K
26 Heregulin induces resistance to lapatinib-mediated growth inhibition of HER2-amplified cancer cells Cancer Science 104: 1618-1625, 2013 (Sato Y), Yashiro M, (Takakura N)
27 New molecular staging with G-factors (VEGF-C and Reg IV) by supplementing TNM classification in colorectal cancers Oncology Reports 30: 2609-2616, 2013 Sawada T, Yashiro M, (Sentani K), (Oue N), (Yasui W), (Miyazaki K), (Kai K), (Fujita H), (Nakamura K), Maeda K, (Kakeji Y), (Natsugoe S), (Shirabe K), (Nomura S), (Shimada Y), (Tomita N), Hirakawa K, (Maehara Y)
28 Binding of the sialic acid-binding Lectin, siglec-9, to the membrane mucin, MUC1, induces recruitment of β-catenin and subsequent cell growth Journal of Biological Chemistry 288: 31842-31852, 2013 (Tanida S), (Akita K), (Ishida A), (Mori Y), (Toda M), (Inoue M), (Ohta M), Yashiro M, Sawada T, Hirakawa K, (Nakada H)
29 Comparison of prognosis between patients of pancreatic head cancer with and without obstructive jaundice at diagnosis International Journal of Surgery 11: 344-349, 2013 Nakata B, Amano R, Kimura K, Hirakawa K
30 Impact of preoperative diabetes mellitus on clinical outcome after pancreatectomy International Journal of Surgery 11: 757–761, 2013 Nakata B, Ishikawa T, Amano R, Kimura K, Hirakawa K
31 Prognostic value of preoperative inflammation-based prognostic scores in patients with stage IV colorectal cancer who undergo palliative resection of asymptomatic primary tumors Anticancer Research 33: 5567-5573, 2013 Maeda K, Shibutani M, Otani H, Nagahara H, Sugano K, Ikeya T, Amano R, Kimura K, Sakurai K, Kubo N, Muguruma K, Tanaka H, Inoue T, Hirakawa K
32 Port site metastasis after laparoscopic-assisted distal gastrectomy (LADG) International Surgery 98: 363–366, 2013 Sakurai K, Tanaka H, Lee T, Muguruma K, Kubo N, Yashiro M, Ohira M, Hirakawa K

2012年度

No Title Journal Author
1 Concurrent biological targeting therapy of squamous cell carcinoma of the esophagus with cetuximab and trastuzumab Oncology Reports 28: 49-54, 2012 Yamazaki M, Yamashita Y, Kubo N, Yashiro M, Ohira M, Ako E, Tanaka H, Muguruma K, Sawada T, Hirakawa K
2 Spontaneously complete regression of pseudolymphoma of the remnant pancreas after pancreaticoduodenectomy Pancreatology 12: 215-218, 2012 Nakata B, Amano R, Matsuoka J, (Sugimori S), (Ohsawa M), (Wakasa K), (Egashira Y), Kimura K, Yamada N, Hirakawa K
3 Myositis ossificans associated with subclinical idiopathic thrombocytopenic purpura: report of a case International Journal of Surgical Pathology 19: 207-211, 2011 Onoda N, Yamazoe S, (Tanaka T), Ishikawa T, (Wakasa K), Hirakawa K
4 Successful surgical treatment of advanced follicular thyroid carcinoma with tumor thrombus infiltrating the superior vena cava Surgery Today 42: 185-190, 2012 Onoda N, Nakamura M, (Hosono M), (Sasaki Y), Kawajiri H, Takashima T, Ishikawa T, Hirakawa K
5 NC-6301, a polymeric micelle rationally optimized for effective release of docetaxel, is potent but is less toxic than native docetaxel in vivo International Journal of Nanomedicine 7: 2713–2727, 2012 (Harada M), (Iwata C), (Saito H), (Ishii K), (Hayashi T), Yashiro M, Hirakawa K, (Miyazono K), (Kato Y), (Kano R M)
6 Correlation between efficacy of PSK postoperative adjuvant immunochemotherapy for gastric cancer and expression of MHC class I Investigational New Drugs 30(4): 1352-1360, 2012 Ito G, Tanaka H, Ohira M, Yoshii M, Muguruma K, Kubo N, Yashiro M, Yamada N, Maeda K, Sawada T, Hirakawa K
7 Foretinib (GSK1363089), a multi-kinase inhibitor of MET and VEGFRs, inhibits growth of gastric cancer cell lines by blocking inter-receptor tyrosine kinase networks a multi-kinase inhibitor of MET and VEGFRs (Kataoka Y), (Mukohara T), (Tomioka H), (Funakoshi Y), (Kiyota N), (Fujiwara Y), Yashiro M, Hirakawa K, (Hirai M), (Minami H)
8 Parathyroid hormone-related protein expression, in combination with nodal status, predicts bone metastasis and prognosis of breast cancer patients Experimental and Therapeutic Medicine 3: 963-968, 2012 Takagaki K, Takashima T, Onoda N, Tezuka K, Noda E, Kawajiri H, Ishikawa T, Hirakawa K
9 Expression of forkhead box P3 in tumour cells causes immunoregulatory function of signet ring cell carcinoma of the stomach British Journal of Cancer 106: 1668-1674, 2012 Yoshii M, Tanaka H, Ohira M, Muguruma K, Iwauchi T, Lee T, Sakurai K, Kubo N, Yashiro M, Sawada T, Hirakawa K
10 CD133 is a useful surrogate marker for predicting chemosensitivity to neoadjuvant chemotherapy in breast cancer PLoS One 7(9): e45865, 2012 Aomatsu N, Yashiro M, Kashiwagi S, Takashima T, Ishikawa T, (Ohsawa M), (Wakasa K), Hirakawa K
11 VEGF-A/VEGFR-2 signaling plays an important role for the motility of pancreas cancer cells Annals of Surgical Oncology 19(8): 2733-2743, 2012 Doi Y, Yashiro M, Yamada N, Amano R, Noda S, Hirakawa K
12 Cancer-associated orthotopic myofibroblasts stimulates the motility of gastric carcinoma cells Cancer Science 103(4): 797-805, 2012 Fuyuhiro Y, Yashiro M, Noda S, Matsuoka J, Hasegawa T, Kato Y, Sawada T, Hirakawa K
13 MUC5AC protects pancreatic cancer cells from TRAIL-induced death pathways International Journal of Oncology 42(3): 887-893, 2013 (Hoshi H), Sawada T, (Uchida M), (Iijima H), Kimura K, Hirakawa K, (Wanibuchi H)
14 Breast conserving surgery and sentinel lymph node biopsy under local anesthesia for breast cancer Journal of Cancer Therapy 3: 810-813, 2012 Kashiwagi S, Onoda N, Takashima T, Asano Y, Aomatsu N, Nakamura M, Kawajiri H, Ishikawa T, Hirakawa K
15 c-Kit expression as a prognostic molecular marker in patients with basal-like breast cancer British Journal of Surgery 100(4): 490-496, 2013 Kashiwagi S, Yashiro M, Takashima T, Aomatsu N, Kawajiri H, Ogawa Y, Onoda N, Ishikawa T, Wakasa K, Hirakawa K
16 Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β Journal of Pathology 228(3): 391-404, 2012 (Katsuno Y), (Ehata S), Yashiro M, (Yanagihara K), Hirakawa K, (Miyazono K)
17 Efficacy and feasibility of neoadjuvant chemotherapy with FEC 100 followed by weekly paclitaxel for operable breast cancer Oncology Letters 4(4): 612-616, 2012 Kawajiri H, Takashima T, Onoda N, Kashiwagi S, Noda S, Ishikawa T, (Wakasa K), Hirakawa K
18 A comparative study of single-incision versus conventional multiport laparoscopic ileocecal resection for Crohn's disease with strictures Asian Journal of Endoscopic Surgery 5(3): 118-122, 2012 Maeda K, Noda E, Nagahara H, Inoue T, Takii M, (Watanabe K), (Yamagami H), (Sogawa M), (Kamata N), Hirakawa K
19 The usefulness of double-balloon enteroscopy in gastrointestinal stromal tumors of the small bowel with obscure gastrointestinal bleeding Internal Medicine 51(19): 2675-2682, 2012 (Nakatani M), (Fujiwara Y), (Nagami Y), (Sugimori S), (Kameda N), (Machida H), (Okazaki H), (Yamagami H), (Tanigawa T), (Watanabe K), (Watanabe T), (Tominaga K), Noda E, Maeda K, (Ohsawa M), (Wakasa K), Hirakawa K, (Arakawa T)
20 A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and open colectomy for colon cancer Journal of Cancer 3: 49-57, 2012 Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K
21 Meta-analysis of the results of randomized controlled trials that compared laparoscopic and open surgery for acute appendicitis Journal of Gastrointestinal Surgery 16(10): 1929-1939, 2012 Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K
22 Pattern of initial metastasis in the cervical lymph node from papillary thyroid carcinoma Surgery Today 43(2): 178-184, 2013 Onoda N, Ishikawa T, Kawajiri H, Takashima T, Hirakawa K
23 Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis Journal of Controlled Release 159(2): 189-196, 2012 (Rafi M), (Cabral H), (Kano MR), (Mi P), (Iwata C), Yashiro M, Hirakawa K, (Miyazono K), (Nishiyama N), (Kataoka K)
24 Amplification of the human epidermal growth factor receptor 2 gene in differentiated thyroid cancer correlates with telomere shortening International Journal of Oncology 42(5): 1589-1596, 2013 (Sugishita Y), (Kammori M), (Yamada O), (Poon SS), (Kobayashi M), Onoda N, (Yamazaki K), (Fukumori T), (Yoshikawa K), (Onose H), (Ishii S), (Yamada E), (Yamada T)
25 Association of location of lymph node metastases with postoperative recurrence of esophageal squamous cell carcinoma Anticancer Research 32(8): 3421-3426, 2012 Tanaka H, Ohira M, Kubo N, Muguruma K, Yamashita Y, Sawada T, Hirakawa K
26 Impact of adjuvant immunochemotherapy using protein-bound polysaccharide-K on overall survival of patients with gastric cancer Anticancer Research 32(8): 3427-3433, 2012 Tanaka H, Muguruma K, Ohira M, Kubo N, Yamashita Y, Maeda K, Sawada T, Hirakawa K
27 Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Nature Medicine 18(8): 1254-1261, 2012 (Walter S), (Weinschenk T), (Stenzl A), (Zdrojowy R), (Pluzanska A), (Szczylik C), (Staehler M), (Brugger W), (Dietrich PY), (Mendrzyk R), (Hilf N), (Schoor O), (Fritsche J), (Mahr A), (Maurer D), (Vass V), (Trautwein C), (Lewandrowski P), (Flohr C), (Pohla H), (Stanczak JJ), (Bronte V), (Mandruzzato S), (Biedermann T), (Pawelec G), (Derhovanessian E), (Yamagishi H), (Miki T), (Hongo F), (Takaha N), Hirakawa K, Tanaka H, (Stevanovic S), (Frisch J), (Mayer-Mokler A), (Kirner A), (Rammensee HG), (Reinhardt C), (Singh-Jasuja H)
28 A case of young breast cancer in which delivery was successfully achieved after postoperative chemotherapy under ovarian function protection using GnRH agonist World Journal of Surgical Medical and Radiation Oncology 1: 97-102, 2012 Kashiwagi S, Takashima T, Aomatsu N, Kawajiri H, Onoda N, Ishikawa T, Hirakawa K
29 Successful resection of esophageal carcinoma associated with double aortic arch: a case report Anticancer Research 32(8) : 3351-3355, 2012 Kubo N, Ohira M, Yamashita Y, Sakurai K, Tanaka H, Muguruma K, Kimura K, Nagahara H, Noda E, Amano R, Yashiro M, Maeda K, Hirakawa K
30 A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and open colectomy for colon cancer Journal of Cancer 3: 49-57, 2012 Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K
31 Polymeric micelles incorporating (1,2-diaminocyclohexane)platinum (II) suppress the growth of orthotopic scirrhous gastric tumors and their lymph node metastasis Journal of Controlled Release 159: 189-96, 2012 (Rafi M), (Cabral H), (Kano MR), (Mi P), (Iwata C), Yashiro M, Hirakawa K, (Miyazono K), (Nishiyama N), (Kataoka K)
32 Multipeptide immune response to cancer vaccine IMA901 after single-dose cyclophosphamide associates with longer patient survival Nature Medicine 18: 1254-1261, 2012 (Walter S), (Weinschenk T), (Stenzl A), (Zdrojowy R), (Pluzanska A), (Szczylik C), (Staehler M), (Brugger W), (Dietrich PY), (Mendrzyk R), (Hilf N), (Schoor O), (Fritsche J), (Mahr A), (Maurer D), (Vass V), (Trautwein C), (Lewandrowski P), (Flohr C), (Pohla H), (Stanczak JJ), (Bronte V), (Mandruzzato S), (Biedermann T), (Pawelec G), (Derhovanessian E), (Yamagishi H), (Miki T), (Hongo F), (Takaha N), Hirakawa K, Tanaka H, (Stevanovic S), (Frisch J), (Mayer-Mokler A), (Kirner A), (Rammensee HG), (Reinhardt C), (Singh-Jasuja H)
33 Multicenter, phase II clinical trial of cancer vaccination for advanced esophageal cancer with three peptides derived from novel cancer-testis antigens Journal of Translational Medicine 10:141 (Online 9pages), 2012 (Kono K), (Iinuma H), (Akutsu Y), Tanaka H, (Hayashi N), (Uchikado Y), (Noguchi T), (Fujii H), (Okinaka K), (Fukushima R), (Matsubara H), Ohira M, (Baba H), (Natsugoe S), (Kitano S), (Takeda K), (Yoshida K), (Tsunoda T), (Nakamura Y)

2011年度

No Title Journal Author
1 Transforming growth factor-β decreases the cancer-initiating cell population within diffuse-type gastric carcinoma cells Oncogene 30(14): 1693-1705, 2011 (Ehata S), (Johansson E), (Katayama R), (Koike S), (Watanabe A), (Hoshino Y), (Katsuno Y), (Komuro A), (Koinuma D), (Kano MR), Yashiro M, Hirakawa K, (Aburatani H), (Fujita N), (Miyazono K)
2 Meta-analysis of laparoscopy-assisted and open distal gastrectomy for gastric cancer Journal of Surgical Research 171: 479-485, 2011 Ohtani H, Tamamori Y, (Noguchi K), Azuma T, (Fujimoto S), (Oba H), (Aoki T), (Minami M), Hirakawa K
3 THBS4, a novel stromal molecule of diffuse-type gastric adenocarcinomas, identified by transcriptome-wide expression profiling Modern Pathology 24: 1390-1403, 2011 (Forster S), (Gretschel S), (Jons T), Yashiro M, (Kemmner W)
4 Upregulation of cancer-associated myofibroblasts by TGF-β from scirrhous gastric carcinoma cells British Journal of Cancer 105: 996-1001, 2011 Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y, Kato Y, Hasegawa T, Sawada T, Hirakawa K
5 HER3 overexpression as an independent indicator of poor prognosis for patients with curatively resected pancreatic cancer Oncology 81: 192-198, 2011 Hirakawa T, Nakata B, Amano R, Kimura K, Shimizu S, Ohira G, Yamada N, Ohira M, Hirakawa K
6 Anti-protein-bound polysaccharide-K monoclonal antibody binds the active structure and neutralizes direct antitumor action of the compound Oncology Reports 25: 905-913, 2011 (Hoshi H), (Saito H), (Iijima H), (Uchida M), (Wada T), Ito G, Tanaka H, Sawada T, Hirakawa K.
7 Tumor-associated MUC5AC stimulates in vivo tumorigenicity of human pancreatic cancer International Journal of Oncology 38: 619-627, 2011 (Hoshi H), Sawada T, (Uchida M), (Saito H), (Iijima H), (Toda-Agetsuma M), (Wada T), Yamazoe S, Tanaka H, Kimura K, (Kakehashi A), (Wei M), Hirakawa K, (Wanibuchi H)
8 Identification of HLA-A*2402-restricted epitope peptide derived from ERas oncogene expressed in human scirrhous gastric cancer Cancer Science 102: 683-689, 2011 Iwauchi T, Tanaka H, Yamazoe S, Yashiro M, Yoshii M, Kubo N, Muguruma K, Sawada T, Ohira M, Hirakawa K
9 Effects of acute and chronic hypoxia on the radiosensitivity of gastric and esophageal cancer cells Anticancer Research 31: 3369-3375, 2011 Kato Y, Yashiro M, Fuyuhiro Y, Kashiwagi S, Matsuoka J, Hirakawa T, Noda S, Aomatsu N, Hasegawa T, Matsuzaki T, Sawada T, Ohira M, Hirakawa K
10 Advantages of adjuvant chemotherapy for patients with triple-negative breast cancer at Stage II: usefulness of prognostic markers E-cadherin and Ki67 Breast Cancer Research 13(6):R122, 2011 Kashiwagi S, Yashiro M, Takashima T, Aomatsu N, Ikeda K, Ogawa Y, Ishikawa T, Hirakawa K
11 Role of the stemness factors Sox2, Oct3/4, and nanog in gastric carcinoma Journal of Surgical Research 174: 130-135, 2012 Matsuoka J, Yashiro M, Sakurai K, Kubo N, Tanaka H, Muguruma K, Sawada T, Ohira M, Hirakawa K.
12 RhoA/ROCK signaling mediates plasticity of scirrhous gastric carcinoma motility Clinical and Experimental Metastasis 28: 627-636, 2011 Matsuoka T, Yashiro M, Kato Y, Shinto O, Kashiwagi S, Hirakawa K
13 PI3K/Akt signalling is required for the attachment and spreading, and growth in vivo of metastatic scirrhous gastric carcinoma British Journal of Cancer 106: 1535–1542, 2012 Matsuoka T, Yashiro M, Nishioka N, Hirakawa K, (Olden K), (Roberts JD)
14 Dysregulated upregulation of T-cell immunoglobulin and mucin domain-3 on mucosal T helper 1 cells in patients with Crohn's disease Scandinavian Journal of Gastroenterology 46: 701–709, 2011 (Morimoto K), (Hosomi S), (Yamagami H), (Watanabe K), (Kamata N), (Sogawa M), (Machida H), (Okazaki H), (Tanigawa T), Nagahara H, Noda E, (Tominaga K), (Watanabe T), (Fujiwara Y), Maeda K, Hirakawa K, (Arakawa T)
15 Phase I study of S-1 in combination with trastuzumab for HER2-positive metastatic breast cancer Anticancer Research 31: 3035-3040, 2011 (Nakayama T), (Morita S), Takashima T, (Kamigaki S), (Yoshidome K), (Ito T), (Taguchi T), (Sakamoto J), (Noguchi S)
16 Linoleic acid enhances angiogenesis through suppression of angiostatin induced by plasminogen activator inhibitor 1 British Journal of Cancer 105: 1750–1758, 2011 Nishioka N, Matsuoka T, Yashiro M, Hirakawa K, (Olden K), (Roberts JD)
17 Plasminogen activator inhibitor 1 RNA interference suppresses gastric cancer metastasis in vivo Cancer Science 103: 228-232, 2012 Nishioka N, Matsuoka T, Yashiro M, Hirakawa K, (Olden K), (Roberts JD)
18 Predictive value of expression of ERCC 1 and GST-p for 5-fluorouracil/oxaliplatin chemotherapy in advanced colorectal cancer Hepatogastroenterology 59: 130-133, 2012 Noda E, Maeda K, Inoue T, Fukunaga S, Nagahara H, Shibutani M, Amano R, Nakata B, Tanaka H, Muguruma K, Yamada N, Yashiro M, Ohira M, Ishikawa T, Hirakawa K
19 Borrmann's macroscopic criteria and p-Smad2 expression are useful predictive prognostic markers for cytology-positive gastric cancer patients without overt peritoneal metastasis Annals of Surgical Oncology 18: 3718-3725, 2011 Noda S, Yashiro M, Toyokawa T, Morimoto J, Shinto O, Muguruma K, Sawada T, Hirakawa K
20 A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for rectal cancer Journal of Gastrointestinal Surgery 15: 1375-1385; 2011 Ohtani H, Tamamori Y, Azuma T, (Mori Y), Nishiguchi Y, Maeda K, Hirakawa K.
21 A meta-analysis of the short- and long-term results of randomized controlled trials that compared laparoscopy-assisted and conventional open surgery for colorectal cancer Journal of Cancer 2: 425-434: 2011 Ohtani H, Tamamori Y, Arimoto Y, Nishiguchi Y, Maeda K, Hirakawa K.
22 A FGFR2 inhibitor, Ki23057, enhances the chemosensitivity of drug-resistant gastric cancer cells Cancer Letters 307: 47-52, 2011 Qiu H, Yashiro M, (Zhang X), (Miwa A), Hirakawa K
23 Bone morphogenetic protein-2/4 play tumor suppressive roles in human diffuse-type gastric carcinoma The American Journal of Pathology 179: 2920–2930, 2011 (Shirai Y), (Ehata S), Yashiro M, (Yanagihara K), Hirakawa K, (Miyazono K)
24 Intraperitoneal administration of an adenovirus vector carrying REIC/Dkk-3 suppresses peritoneal dissemination of scirrhous gastric carcinoma Oncology Reports 25: 989-995, 2011 (Than SS), (Kataoka K), (Sakaguchi M), (Murata H), (Abarzua F), (Taketa C), (Du G), Yashiro M, (Yanagihara K), (Nasu Y), (Kumon H), (Huh NH)
25 Identification of HLA-A*0201- and A*2402-restricted epitopes of mucin 5AC expressed in advanced pancreatic cancer Pancreas 40: 896-904, 2011 Yamazoe S, Tanaka H, Iwauchi T, Yoshii M, Ito G, Amano R, Yamada N, Sawada T, Ohira M, Hirakawa K
26 An EGFR inhibitor enhances the efficacy of SN38, an active metabolite of irinotecan, in SN38-refractory gastric carcinoma cells British Journal of Cancer 105: 1522–1532, 2011 Yashiro M, Qiu H, Hasegawa T, Zhang X, Matsuzaki T, Hirakawa K
27 Postoperative long-term evaluation of interposition reconstruction compared with Roux-en-Y after total gastrectomy in gastric cancer: prospective randomized controlled trial The American Journal of Surgery 202: 247-253, 2011 (Ishigami S), (Natsugoe S), (Hokita S), (Aoki T), (Kashiwagi H), Hirakawa K, Sawada T, (Yamamura Y), (Itoh S), (Hirata K), (Ohta K), (Mafune K), (Nakane Y), (Kanda T), (Furukawa H), (Sasaki I), (Kubota T), (Kitajima M), (Aikou T)

2010年度

No Title Journal Author
1 Reduction of 15-hydroxyprostaglandin dehydrogenase expression is an independent predictor of poor survival associated with enhanced cell proliferation in gastric adenocarcinoma Cancer Science 101: 550-558, 2010 T.Tatsuwaki, T.Tanigawa, T.Watanabe, H.Machida, H.Okazaki, H.Yamagami, M.Shiba, K.Watanabe, K.Tominaga, Y.Fujiwara, N.Oshitani, K.Muguruma, T.Sawada, K.Hirakawa, K.Higuchi, T.Arakawa
2 In vitro and in vivo evidence that a combination of lapatinib plus S-1 is a promising treatment for pancreatic cancer Cancer Science 101(2):468-473;2010 M.Komoto, B.Nakata, T.Nishii, H.Kawajiri, O.Shinto, R.Amano, N.Yamada, M.Yashiro, K.Hirakawa
3 Hypoxia upregulates adhesion ability to peritoneum through a transforming growth factor-β-dependent mechanism in diffuse-type gastric cancer cells EUROPEAN JOURNAL OF CANCER 46:995-1005;2010 S.Noda, M.Yashiro, T.Nishii, K.Hirakawa
4 Inhibitory effect of a TGFβ receptor type-I inhibitor, Ki26894, on invasiveness of scirrhous gastric cancer cells British Journal of Cancer 102(5):844-851;2010 O.Shinto, M.Yashiro, H.Kawajiri, K.Shimizu, T.Shimizu, A.Miwa, K.Hirakawa
5 Establishment and characterization of a new hypoxia-resistant cancer cell line, OCUM-12/Hypo, derived from a scirrhous gastric carcinoma British Journal of Cancer 102(5):898-907;2010 Y.Kato, M.Yashiro, S.Noda,M.Tendo, S.Kashiwagi,Y.Doi, T.Nishii, J.Matsuoka, Y.Fuyuhiro,O.Shinto, T.Sawada, M.Ohira, K.Hirakawa
6 Synergistic antitumor effects of FGFR2 inhibitor with 5-fluorouracil on scirrhous gastric carcinoma International Journal of Cancer 126:1004-1016;2010 M.Yashiro, O.Shinto, K.Nakamura, M.Tendo, T.Matsuoka, T.Matsuzaki, R.Kaizaki, A.Miwa, K.Hirakawa
7 Establishment and characterization of multidrug-resistant gastric cancer cell lines Anticancer Research 30:915-922;2010 X.Zhang, M.Yashiro, H.Qiu, T.Nishii, T.Matsuzaki, K.Hirakawa
8 Plasma pharmacokinetics after combined therapy of gemcitabine and oral S-1 for unresectable pancreatic cancer Journal of Experimental & Clinical Cancer Research:29(15)(Online 7pages); 2010 B.Nakata, R.Amano, S.Nakao, T.Tamura, O.Shinto, T.Hirakawa, Y.Okita, N.Yamada, K.Hirakawa
9 Expression of a hypoxia-associated protein, carbonic anhydrase-9, correlates with malignant phenotypes of gastric carcinoma Digestion 82: 246-251, 2010 Kato Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Fuyuhiro Y, Doi Y, Hirakawa K
10 Myofibroblasts are associated with the progression of scirrhous gastric carcinoma Experimental and Therapeutic Medicine 1: 547-551, 2010 Fuyuhiro Y, Yashiro M, Noda S, Kashiwagi S, Matsuoka J, Doi Y, Kato Y, Muguruma K, Sawada T, Hirakawa K
11 Combination effect of TGF-β receptor kinase inhibitor with 5-FU analog S1 on lymph node metastasis of scirrhous gastric cancer in mice Cancer Science 101: 1846-1852, 2010 Shinto O, Yashiro M, Kawajiri H, (Shimizu K), (Shimizu T), (Miwa A), Hirakawa K
12 Significance of phospho-vascular endothelial growth factor receptor-2 expression in pancreatic cancer Cancer Science 101: 1529-1535, 2010 Doi Y, Yashiro M, Yamada N, Amano R, Ohira G, Komoto M, Noda S, Kashiwagi S, Kato Y, Fuyuhiro Y, Hirakawa K
13 Significance of E-cadherin expression in triple-negative breast cancer British Journal of Cancer 103: 249-255, 2010 Kashiwagi S, Yashiro M, Takashima T, Nomura S, Noda S, Kawajiri H, Ishikawa T, (Wakasa K), Hirakawa K
14 Biodistribution of humanized anti-VEGF monoclonal antibody/bevacizumab on peritoneal metastatic models with subcutaneous xenograft of gastric cancer in mice Cancer Chemotherapy and Pharmacology 66: 745-753, 2010 (Yagi Y), (Fushida S), (Harada S), (Tsukada T), (Kinoshita J), (Oyama K), (Fujita H), (Ninomiya I), (Fujimura T), (Kayahara M), (Kinuya S), Yashiro M, Hirakawa K, (Ohta T)
15 Mutations in TGFbeta-RⅡ and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability BMC Cancer 10: (Online 6pages); 2010 Yashiro M, Hirakawa K, (Boland CR)
16 A meta-analysis of randomized controlled trials that compared laparoscopy-assisted and open distal gastrectomy for early gastric cancer Journal of Gastrointestinal Surgery 14: 958-964, 2010 Ohtani H, Tamamori Y, (Noguchi K), Azuma T, (Fujimoto S), (Oba H), (Aoki T), (Minami M), Hirakawa K
17 Elevated dietary linoleic acid increases gastric carcinoma cell invasion and metastasis in mice British Journal of Cancer 103: 1182-1191, 2010 Matsuoka T, (Adair JE), (Lih FB), (Hsi LC), (Rubino M), (Eling TE), (Tomer KB), Yashiro M, Hirakawa K, (Olden K), (Roberts JD)
18 Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity Oncology Reports 24: 1637-1643, 2010 Tanaka H, Shinto O, Yashiro M, Yamazoe S, Iwauchi T, Muguruma K, Kubo N, Ohira M, Hirakawa K
19 Significance of keratinocyte growth factor receptor in the proliferation of biliary tract cancer Anticancer Research 30: 4115-4122, 2010 Amano R, Yamada N, Doi Y, Yashiro M, Ohira M, (Miwa A), Hirakawa K
20 RNA interference suppression of mucin 5AC (MUC5AC) reduces the adhesive and invasive capacity of human pancreatic cancer cells Journal of Experimental & Clinical Cancer Research 29: (53): (Online 7 pages), 2010 Yamazoe S, Tanaka H, Sawada T, Amano R, Yamada N, Ohira M, Hirakawa K
21 Randomized study of taxane versus TS-1 in women with metastatic or recurrent breast cancer (SELECT BC) Japanese Journal of Clinical Oncology 40: 811-814, 2010 (Mukai H), Takashima T, (Hozumi Y), (Watanabe T), (Murakami S), (Masuda N), (Mituyama S), (Ohmura T), (Yajima T), (Ohashi Y)
22 Effects of valproic acid on the cell cycle and apoptosis through acetylation of histone and tubulin in a scirrhous gastric cancer cell line Journal of Experimental & Clinical Cancer Research 29: (149): (Online11pages), 2010 (Yagi Y), (Fushida S), (Harada S), (Kinoshita J), (Makino I), (Oyama K), (Tajima H), (Fujita H), (Takamura H), (Ninomiya I), (Fujimura T), (Ohta T), Yashiro M, Hirakawa K
23 Angioleiomyoma of the small intestine detected by double-balloon enteroscopy Gastrointestinal Endoscopy 72: 187-188, 2010 (Nakatani M), (Fujiwara Y), (Kameda N), (Okazaki H), (Watanabe T), (Tominaga K), (Arakawa T), Noda E, Inoue T, Maeda K, Hirakawa K,(Wakasa K)
24 Cancer-stromal interactions in scirrhous gastric carcinoma Cancer Microenvironment 3: 127-135, 2010 Yashiro M, Hirakawa K
25 Phosphorylated Smad2 in advanced stage gastric carcinoma BMC Cancer 10(652): (Online 8 pages), 2010 Shinto O, Yashiro M, Toyokawa T, Nishii T, Kaizaki R, Matsuzaki T, Noda S, Kubo N, Tanaka H, Doi Y, Ohira M, Muguruma K, Sawada T, Hirakawa K
26 Clinical significance of the expression of connexin26 in colorectal cancer Journal of Experimental & Clinical Cancer Research 29: (79): (Online 6 pages), 2010 Nomura S, Maeda K, Noda E, Inoue T, Fukunaga S, Nagahara H, Hirakawa K
27 Phenotypic change and accumulation of smooth muscle cells in strictures in Crohn’s disease: relevance to local angiotensin II system Journal of Gastroenterology 45: 821-830, 2010 (Suekane T), (Ikura Y), (Watanabe K), (Arimoto J), (Iwasa Y), (Sugama Y), (Kayo S), (Sugioka K), (Naruko T), Maeda K, Hirakawa K, (Arakawa T), (Ueda M)
28 Phase Ⅱ trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer(JFMC27-9902 Step2) Oncology 79: 337-342, 2010 Nakata B, (Tsuji A), (Mitachi Y), Taenaka N, (Kamano T), (Oikawa K), Onoda N, (Kambe M), (Takahashi M), (Shirasaka T), (Morita S), (Sakamoto J), (Tanaka Y), (Saji S), Hirakawa K
29 Monoclonal antibodies to fibroblast growth factor receptor 2 effectively inhibit growth of gastric tumor xenografts Clinical Cancer Research 16: 5750-5758, 2010 (Zhao WM), (Wang L), (Park H), (Chhim S), (Tanphanich M), Yashiro M, (Kim KJ)
30 Proteomic differential display analysis shows up-regulation of 14-3-3 sigma protein in human scirrhous-type gastric carcinoma cells Anticancer Research 30: 4459-4465,2010 (Kuramitsu Y), (Baron B), (Yoshino S), (Zhang X), (Tanaka T), Yashiro M, Hirakawa K, (Oka M), (Nakamura K)
31 Phase Ⅱ trial of S-1 plus low-dose cisplatin for unresectable and recurrent gastric cancer(JFMC27-9902 Step2) Oncology 79: 337-342, 2010 Nakata B, (Tsuji A), (Mitachi Y), Taenaka N, (Kamano T), (Oikawa K), Onoda N,(Kambe M), (Takahashi M), (Shirasaka T), (Morita S), (Sakamoto J), (Tanaka Y), (Saji S), Hirakawa K

2009年度

No Title Journal Author
1 DNA methyltransferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells Cancer Science 100(1); 181-188, 2009 H.Qiu, M.Yashiro, O.Shinto, T.Matsuzaki, K.Hirakawa
2 Diffuse-type gastric carcinoma:progression,angiogenesis,and transforming growth factor β signaling JNCI 101(8);592-604,2009 A.Komuro, M.Yashiro, C.Iwata, Y.Morishita, E.Johansson, Y.Matsumoto, A.Watanabe, H.Aburatani, H.Miyoshi, K.Kiyono, Y.Shirai, H.Suzuki, K.Hirakawa, M.Kano, K.Miyazono
3 Co-expression of keratinocyte growth factor and K-sam is an independent prognostic factor in gastric carcinoma ONCOLOGY REPORTS 21;875-880,2009 T.Toyokawa, M.Yashiro, K.Hirakawa
4 DNA methyltranferase inhibitor 5-aza-CdR enhances the radiosensitivity of gastric cancer cells Cancer Sci 100(1);181-188,2009 H.Qiu, M.Yashiro, O.Shinto, T.Matsuzaki, K.Hirakawa
5 Local angiotensin Ⅱ-generation in human gastric cancer : correlation with tumor progression through the activation of ERK1/2, NF-kB and survivin INTERNATIONAL JOURNAL OF ONCOLOGY 34;1573-1582,2009 J.Kinoshita, S.Fushida, S.Harada, Y.Yagi, H.Fujita, S.Kinami, I.Ninomiya, T.Fujimura, M.Kayahara, M.Yashiro, K.Hirakawa, T.Ohta
6 Expression of Eras oncogene in gastric carcinoma Anticancer Research 29;2189-2194,2009 R.Kaizaki, M.Yashiro, O.Shinto, K.Yasuda, T.Matsuzaki, T.Sawada, K.Hirakawa
7 Cushing's syndrome by left adrenocortical adenoma synchronously associated with primary aldosteronism by right adrenocortical adenoma:report of a case Endocrine Journal 56(3);495-502,2009 N.Onoda, T.Ishikawa, K.Nishiko, H.Tahara, M.Inaba, K.Wakasa, T.Sumi, T.Yamazaki, K.Shigematsu, K.Hirakawa
8 Gemcitabine sensitivity-related mRNA expression in endoscopic ultrasound-guided fine-needle aspiration biopsy of unresectable pancreatic cancer Journal of Experimental & Clinical Cancer Research 28(83);2009 R.Ashida, B.Nakata, M.Shigekawa, N.Mizuno, A.Sawaki, K.Hirakawa, T.Arakawa, K.Yamao
9 Dual therapeutic efficacy of vinblastine as a unique chemotherapeutic agent capable of inducing dendritic cell maturation Cancer Res 69(17);6987-6994,2009 H.Tanaka, H.Matsushima, A.Nishibu, B.E.Clausen, A.Takashima
10 Classification of chemotherapeutic agents based on their differential In vitro effects on dendritic cells Cancer Res 69(17);6978-6986,2009 H.Tanaka, H.Matsushima, N.Mizumoto, A.Takashima
11 Epigenetic regulation of the embryonic oncogene Eras in gastric cancer cells International Journal of Oncology 35:997-1003;2009 M.Yashiro, K.Yasuda, T.Nishii, R.Kaizaki, T.Sawada, M.Ohira, K.Hirakawa
12 Vitamin D receptor expression is associated with colon cancer in ulcerative colitis Oncology Reports 22:1021-1025;2009 K.Wada, H.Tanaka, K.Maeda, T.Inoue, E.Noda, R.Amano, N.Kubo, K.Muguruma, N.Yamada, M.Yashiro, T.Sawada, B.Nakata, M.Ohira, K.Hirakawa
13 Effects of VEGFR-3 phosphorylation inhibitor on lymph node metastasis in an orthotopic diffuse-type gastric carcinoma model British Journal of cancer 101:1100-1106;2009 M.Yashiro, O.Shinto, K.Nakamura, M.Tendo, T.Matsuoka, T.Matsuzaki, R.Kaizaki, M.Ohira, A.Miwa, K.Hirakawa
14 Direct cancer -stromal interaction increases fibroblast proliferation and enhances invasive properties of scirrhous-type gastric carcinoma cells British Journal of Cancer 101;1365-1373,2009 S.Semba, Y.Kodama, K.Ohnuma, E,Mizuuchi, R.Masuda, M.Yashiro, K.Hirakawa, H.Yokozaki
15 Cancer stem cell-like SP cells have a high adhesion ability to the peritoneum in gastric carcinoma Cancer Sci 100(8):1397-1402;2009 T.Nishii, M.Yashiro, O.Shinto, T.Sawada, M.Ohira, K.Hirakawa
16 Diagnosis of parathyroid carcinoma using immunohistochemical staining against hTERT International Journal of Molecuar Medicine 24:733-741;2009 N.Osawa, N.Onoda, H.Kawajiri, K.Tezuka, T.Takashima, T.Ishikawa, A.Miyauchi, M.Hirokawa, K.Wakasa, K.Hirakawa
17 Synergistic antiproliferative effect of mTOR inhibitors in combination with 5-fluorouracil in scirrhous gastric cancer Cancer Science 100(12):2402-2410;2009-12 T.Matsuzaki, M.Yashiro, R.Kaizaki, K.Yasuda, Y.Doi, T.Sawada, M.Ohira, K.Hirakawa
18 Dislocation of Rabl3 and vasodilator-stimulated phosphoprotein in inactive colon epithelium in patients with Crohn's disease International Journal of Molecular Medicine 24(6):829-835;2009-12 Mizuki.Ohira, N.Oshitani, S.Hosomi, K.Watanabe, H.Yamagami, K.Tominaga, T.Watanabe, Y.Fujiwara, K.Maeda, K.Hirakawa, T.Arakawa
19 HER2 overexpression correlates with survival after curative resection of pancreatic cancer Cancer Science 100(7):1243-1247;2009-7 M.Komoto, B.Nakata, R.Amano, N.Yamada, M.Yashiro, M.Ohira, K.Wakasa, K.Hirakawa
20 Identification of crassin acetate as a new immunosuppressant triggering heme oxygenase-1 expression in dendritic cells Blood 114: 64-73, 2009 (Matsushima H), Tanaka H, (Mizumoto N), (Takashima A)
21 Allelic Imbalance at p53 and Microsatellite Instability Are Predictive Markers for Resistance to Chemotherapy in Gastric Carcinoma. Annals of Surgical Oncology 16:2926–2935;2009 M.Yashiro, T.Inoue,N.Nishioka, T.Matsuoka,C.R.Boland, K.Hirakawa.
22 c-Ski overexpression promotes tumor growth and angiogenesis through inhibition of transforming growth factor-b signaling in diffuse-type gastric carcinoma. Cancer Science 100(10) :1809–1816;2009 K.Kiyono, H.Suzuki, Y.Morishita, A.Komuro, C.Iwata, M.Yashiro, K.Hirakawa, M.Kano, K.Miyazono.

2008年度

No Title Journal Author
1 Enhanced expressions of endothelin-converting enzyme and endothelin receptors in human colonic tissues of crohn's disease J. Clin. Biochem. Nutr., 42; 126-132, 2008. T.Suekane, Y.Ikura, J.Arimoto, M.Nakagawa, C.Kitabayashi, T.Naruko, T.Watanabe, Y.Fujiwara, N.Oshitani, K.Maeda, K.Tanzawa, K.Hirakawa, T.Arakawa, M.Ueda
2 FGFR2-amplified gastric cancer cell lines require FGFR2 and Erbb3 signaling for growth and survival Cancer Research 68(7); 2340-2348, 2008 K.Kunii, L.Davis, J.Gorenstein, H.Hatch, M.Yashiro, A.D.Bacco, C.Elbi, B.Lutterbach
3 A novel transforming growth factorβ receptor kinase inhibitor, A-77, prevents the peritoneal dissemination of scirrhous gastric carcinoma Clinical Cancer Research 14(9); 2850-2860, 2008 H.Kawajiri, M.Yashiro, O.Shinto, K.Nakamura, M.Tendo, S.Takemura, M.Node, Y.Hamashima, T.Kajimoto, T.Sawada, M.Ohira, K.Hirakawa
4 Functional large parathyroid carcinoma extending into the superior mediastinum Annals of thoracic and cardiovascular surgery 14(2); 112-115, 2008 T.Iwata, K.Inoue, R.Morita, S.Mizuguchi, T.Tsukioka, N.Onoda, S.Suehiro
5 Mutations of epidermal growth factor receptor in colon cancer indicate susceptibility or resistance to gefitinib Oncology Reports 19; 1541-1544, 2008 X.Zhang, H.Nagahara, K.Mimori, H.Inoue, T.Sawada, M.Ohira, K.Hirakawa, M.Mori
6 Clinical significance of intra-tumoral sinusoidal structures showing lympho-endothelial immunoreactivity in breast cancer Oncology Reports 20; 25-32, 2008 K.Tezuka, N.Onoda, T.Takashima, T.Ishikawa, T.Wakasa, K.Wakasa, K.Hirakawa
7 Combination therapy of S-1 with selective cyclooxygenase-2 inhibitor for liver metastasis of colorectal carcinoma Anticancer Research 28; 629-638, 2008 A.Tachimori, N.Yamada, R.Amano, M.Ohira, K.Hirakawa
8 Laparoscopic resection of periadrenal paraganglioma. A report of 2 cases Surgical Laparoscopy Endoscopy Percutan Tech 18(3); 310-314, 2008 E.Noda, T.Ishikawa, K.Maeda, T.Inoue, R.Amano, N.Kubo, H.Tanaka, K.Muguruma, Y.Yamashita, M.Yashiro, N.Yamada, N.Onoda, T.Sawada, Y.Nishiguchi, M.Ohira, K.Hirakawa
9 Chemokine receptor CCR7 expression correlates with lymph node metastasis in pancreatic cancer Oncology 74; 69-75, 2008 B.Nakata, S.Fukunaga, E.Noda, R.Amano, N.Yamada, K.Hiirakawa
10 Signet-ring cell carcinoma of the jejunum diagnosed by double balloon enteroscopy Hepato-Gastroenterology 55;1246-1248, 2008 H.Yamagami, N.Oshitani, T.Suekane, K.Aomatsu, N.Kamata, M.Sogawa, K.Watanabe, E.Noda, Y.Ikura, K.Maeda, K.Hirakawa, T.Arakawa
11 Ulcerative colitis-associated colorectal cancer is freqently associated with the microsatellite instability pathway Diseases of the Colon & Rectum 51:1387-1394, 2008 I.Fujiwara, M.Yashiro, N.Kubo, K.Maeda, K.Hirakawa
12 Proliferation of lmmature plasma cells in pouchitis mucosa in patients with ulcerative colitis Inflammatory Bowel Diseases 14(8);1084-1090, 2008 N.Hirata, N.Oshitani, N.Kamata, M.Sogawa, H.Yamagami, K.Watanabe, T.Watanabe, K.Tominaga, Y.Fujiwara, K.Maeda, K.Hirakawa, T.Arakawa
13 Phenotypical and functional study of ghrelin and its receptor in the pathogenesis of grohn's disease Inflammatory Bowel Diseases 14(9);1205-1213, 2008 S.Hosomi, N.Oshitani, N.Kamata, M.Sogawa, H.Yamagami, K.Watanabe, K.Tominaga, T.Watanabe, Y.Fujiwara, K.Maeda, K.Hirakawa, T.Arakawa
14 ICAM1(intercellular adhension molecule 1 (CD54), human rhinovirus receptor) Atlas of Genetics and Cytogenetics in Oncology and Haematology 2008 M.Yashiro
15 Adrenal schwannoma treated with laparoscopic surgery Journal of the Scociety of Laparo en doscopic Surgeons 12;420-425, 2008 N.Onoda, T.Ishikawa, T.Toyokawa, T.Takashima, K.Wakasa, K.Hirakawa
16 Efficacy of S-1 for gastric cancer patients with positive peritoneal lavage cytology Hepato-Gastroenterology 55;1939-1942, 2008 E.Ako, M.Ohira, Y.Yamashita, N.Kubo, K.Muguruma, M.Yashiro, T.Sawada, B.Nakata, Y.Kato, K.Hirakawa
17 Gastric cancer with cervical lymph node metastasis as the first presentation: report of a case International Surgery 93:295-299; 2008 Takashima T, Nakata B, Hatama M, Nomura S, Komoto M, Ishikawa T, Hirakawa K


PAGE TOP